MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Disparities in Access to Spasticity Chemodenervation Specialists in the United States: a National Analysis of Medicare Data

R. Kazerooni, S. Healy, M. Verduzco-Gutierrez (Raleigh, USA)

Meeting: MDS Virtual Congress 2021

Abstract Number: 352

Keywords: Botulinum toxin: Clinical applications: spasticity, Pharmacotherapy

Category: Other

Objective: To explore the variations in access to spasticity chemodenervation specialists across several geographical, ethnic, racial, and population density factors.

Background: Equity in access to healthcare services is a growing area of interest in the medical literature.

Method: This was a retrospective analysis on 2017 Medicare Provider Utilization and Payment Data: Physician and Other Supplier dataset from Center for Medicare & Medicaid Services, which includes data on 34 million fee-for-service beneficiaries.  The primary outcome was Medicare beneficiaries per provider. Providers with substantial adult spasticity chemodenervation practices (SASCPs) were included (defined as having ≥ 11 unique Medicare patients with claims for Current Procedural Terminology codes related to chemodenervation for spasticity).  Ratios were assessed across census defined geographical regions as well as hospital referral regions (HRRs).  Urban was defined as being part of a metropolitan statistical area ≥ 500,000.  A multivariate linear regression model for the top 100 HRRs by beneficiary population was created, using backward stepwise selection to eliminate variables with p-values > 0.10 from final model.

Results: There was a total of 566 providers with SASCPs, the majority of which were neurologists or physiatrists (546/566; 96.5%). Unadjusted results showed lower access in non-urban versus urban areas in the form of higher patient:provider ratios (83,106 vs 51,897). Access ratios were also lower in areas with ≥25% Hispanic populations (141,800 vs 58,600). Multivariate linear regression results showed similar findings with urban HRRs having significantly lower ratios (-45,764 [p=0.004] versus non-urban) and areas with ≥25% Hispanic populations having significantly higher ratios (+96,249 [p=0.003] versus <25% Hispanic areas). Factors such as proportion of population that was white, black, or on Medicaid was not found to be predictive.

Conclusion: This study found that patients in non-urban and highly Hispanic communities face inequities in access to chemodenervation specialists. Future studies should venture to confirm whether findings are limited to this specialization or are part of a larger issue in access to healthcare specialty services. Additionally, strategies to improve access for these underserved communities should be explored.

To cite this abstract in AMA style:

R. Kazerooni, S. Healy, M. Verduzco-Gutierrez. Disparities in Access to Spasticity Chemodenervation Specialists in the United States: a National Analysis of Medicare Data [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/disparities-in-access-to-spasticity-chemodenervation-specialists-in-the-united-states-a-national-analysis-of-medicare-data/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/disparities-in-access-to-spasticity-chemodenervation-specialists-in-the-united-states-a-national-analysis-of-medicare-data/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley